187 related articles for article (PubMed ID: 8769165)
1. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
Vanrenterghem Y; Peeters J
Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
[No Abstract] [Full Text] [Related]
2. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
[No Abstract] [Full Text] [Related]
3. Effect of subclinical rejection on renal allograft histology and function at 6 months.
Rush D; Jeffery J; Trpkov K; Solez K; Gough J
Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
[No Abstract] [Full Text] [Related]
4. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
Buchholz B; Korn A
Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
[No Abstract] [Full Text] [Related]
5. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
[No Abstract] [Full Text] [Related]
6. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
[No Abstract] [Full Text] [Related]
7. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
8. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
[No Abstract] [Full Text] [Related]
9. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
10. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
Kliem V; Repp H; Frei U
Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
[No Abstract] [Full Text] [Related]
11. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ
Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
[No Abstract] [Full Text] [Related]
13. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
[No Abstract] [Full Text] [Related]
14. Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation.
Vanrenterghem Y; Waer M; Roels L; Christiaens R; Gruwez J; Michielsen P
Transplant Proc; 1990 Aug; 22(4):1691-2. PubMed ID: 2389434
[No Abstract] [Full Text] [Related]
15. Rapamycin in a porcine renal transplant model.
Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
[No Abstract] [Full Text] [Related]
16. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
Joss N; Rodger RS; McMillan MA; Junor BJ
Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
[TBL] [Abstract][Full Text] [Related]
17. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
Sumethkul V; Jirasiritham S; Chiewsilp P
Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
[No Abstract] [Full Text] [Related]
18. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
20. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML
Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
